dexmedetomidine has been researched along with isoproterenol in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Yamazaki, F; Yuge, N | 1 |
| Bruzzone, A; Copsel, S; Davio, C; Galés, C; Gargiulo, L; Lüthy, IA; Rivero, EM; Sénard, JM | 1 |
| Kobayashi, K; Kohase, H; Nagasaka, H; Ohno, S; Sakagami, H; Uchida, S | 1 |
| Eguchi, R; Kitano, T; Okamatsu-Ogura, Y; Otsuguro, KI; Yamaguchi, S | 1 |
| Ishiguro, M; Kakizaki, R; Narimatsu, E; Nomura, K; Sawamoto, K; Takahashi, K; Uemura, S | 1 |
1 review(s) available for dexmedetomidine and isoproterenol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 other study(ies) available for dexmedetomidine and isoproterenol
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Limb-specific differences in the skin vascular responsiveness to adrenergic agonists.
Topics: Administration, Cutaneous; Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-2 Receptor Agonists; Adrenergic beta-Agonists; Analysis of Variance; Blood Pressure; Dexmedetomidine; Dose-Response Relationship, Drug; Female; Humans; Isoproterenol; Laser-Doppler Flowmetry; Lower Extremity; Male; Microdialysis; Nonlinear Dynamics; Norepinephrine; Phenylephrine; Regional Blood Flow; Regression Analysis; Skin; Skin Temperature; Time Factors; Upper Extremity; Vascular Capacitance; Vasoconstriction; Vasoconstrictor Agents; Young Adult | 2011 |
Differential β₂-adrenergic receptor expression defines the phenotype of non-tumorigenic and malignant human breast cell lines.
Topics: Adrenergic beta-2 Receptor Agonists; Breast Neoplasms; Cell Adhesion; Cell Line; Cell Line, Tumor; Cell Proliferation; Dexmedetomidine; Disease Progression; Epinephrine; Female; Gene Knockdown Techniques; Humans; Isoproterenol; MCF-7 Cells; Phenotype; Receptors, Adrenergic, beta-2; Signal Transduction; Transfection | 2014 |
Induction of Non-Apoptotic Cell Death by Adrenergic Agonists in Human Oral Squamous Cell Carcinoma Cell Lines.
Topics: Adrenergic Agonists; Antineoplastic Agents; Carcinoma, Squamous Cell; Catalase; Cell Death; Cells, Cultured; Child; Clonidine; Dexmedetomidine; DNA Fragmentation; Epinephrine; Humans; Isoproterenol; Mouth Neoplasms; Phenylephrine; Superoxide Dismutase | 2019 |
Opposing functions of α- and β-adrenoceptors in the formation of processes by cultured astrocytes.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Animals; Astrocytes; Cells, Cultured; Cyclic AMP; Dexmedetomidine; Imidazoles; Isoproterenol; Norepinephrine; Prazosin; Rats, Wistar; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Signal Transduction | 2021 |
Dexmedetomidine improves excessive extracellular glutamate-induced synaptic depression (BRAINRES-D-21-00941).
Topics: Animals; Depression; Dexmedetomidine; Dobutamine; Glutamic Acid; Hippocampus; Isoproterenol; Rats; Receptors, Adrenergic; Synaptic Transmission | 2022 |